Advertisement
CNS vs IVZ
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNS is a StrongBuy and IVZ is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNS’s FA Score shows that 1 FA rating(s) are green whileIVZ’s FA Score has 1 green FA rating(s).
- CNS’s FA Score: 1 green, 4 red.
- IVZ’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNS’s TA Score shows that 4 TA indicator(s) are bullish while IVZ’s TA Score has 4 bullish TA indicator(s).
- CNS’s TA Score: 4 bullish, 5 bearish.
- IVZ’s TA Score: 4 bullish, 4 bearish.
Price Growth
CNS (@Investment Managers) experienced а +3.60% price change this week, while IVZ (@Investment Managers) price change was +5.84% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was +2.91%. For the same industry, the average monthly price growth was +4.81%, and the average quarterly price growth was +10.94%.
Reported Earning Dates
CNS is expected to report earnings on Jul 16, 2025.
IVZ is expected to report earnings on Jul 29, 2025.
Industries' Descriptions
@Investment Managers (+2.91% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
| CNS | IVZ | CNS / IVZ | |
| Capitalization | 3.7B | 7.41B | 50% |
| EBITDA | 184M | 1.13B | 16% |
| Gain YTD | -15.155 | -8.641 | 175% |
| P/E Ratio | 28.73 | 12.27 | 234% |
| Revenue | 490M | 5.72B | 9% |
| Total Cash | 265M | 1.93B | 14% |
| Total Debt | 140M | 9.05B | 2% |
CNS | IVZ | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 6 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 34 Fair valued | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 59 | 53 | |
SMR RATING 1..100 | 27 | 82 | |
PRICE GROWTH RATING 1..100 | 59 | 55 | |
P/E GROWTH RATING 1..100 | 65 | 82 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IVZ's Valuation (18) in the Investment Managers industry is in the same range as CNS (34). This means that IVZ’s stock grew similarly to CNS’s over the last 12 months.
IVZ's Profit vs Risk Rating (53) in the Investment Managers industry is in the same range as CNS (59). This means that IVZ’s stock grew similarly to CNS’s over the last 12 months.
CNS's SMR Rating (27) in the Investment Managers industry is somewhat better than the same rating for IVZ (82). This means that CNS’s stock grew somewhat faster than IVZ’s over the last 12 months.
IVZ's Price Growth Rating (55) in the Investment Managers industry is in the same range as CNS (59). This means that IVZ’s stock grew similarly to CNS’s over the last 12 months.
CNS's P/E Growth Rating (65) in the Investment Managers industry is in the same range as IVZ (82). This means that CNS’s stock grew similarly to IVZ’s over the last 12 months.
| CNS | IVZ | |
|---|---|---|
| RSI ODDS (%) | N/A | 7 days ago 66% |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 62% | 2 days ago 72% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 78% |
| TrendWeek ODDS (%) | 2 days ago 62% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 69% | 2 days ago 70% |
| Advances ODDS (%) | 4 days ago 62% | 4 days ago 70% |
| Declines ODDS (%) | 10 days ago 65% | 14 days ago 67% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 66% |
| Aroon ODDS (%) | 2 days ago 68% | 4 days ago 68% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ABNY | 11.53 | 0.19 | +1.71% |
| YieldMax ABNB Option Income Strategy ETF | |||
| FFSM | 27.15 | 0.42 | +1.57% |
| Fidelity Fundamental Small-Mid Cap ETF | |||
| FRTY | 19.13 | 0.25 | +1.32% |
| Alger Mid Cap 40 ETF | |||
| FENI | 32.88 | 0.34 | +1.04% |
| Fidelity Enhanced International ETF | |||
| GNOV | 36.26 | 0.18 | +0.50% |
| FT Vest U.S. Eq Mod Buffr ETF - Nov | |||
IVZ and
Correlation & Price change
A.I.dvisor indicates that over the last year, IVZ has been closely correlated with JHG. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then JHG could also see price increases.